State of Wyoming’s Vertex Pharmaceuticals VRTX Stock Holding History

State of Wyoming’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$149K	Buy	+300	New	+$133K	0.02%	1194
2026 Q1	–	Sell	-159	Closed	-$72.1K	–	2054
2025 Q4	$72.1K	Sell	159 -157	-50%	-$67.7K	0.01%	1413
2025 Q3	$124K	Buy	+316	New	+$132K	0.01%	1219
2024 Q3	–	Sell	-150	Closed	-$70.3K	–	1909
2024 Q2	$70.3K	Buy	+150	New	+$65.1K	0.01%	1227
2024 Q1	–	Sell	-410	Closed	-$167K	–	1842
2023 Q4	$167K	Buy	410 +241	+143%	+$89K	0.03%	682
2023 Q3	$58.8K	Buy	+169	New	+$59.1K	0.01%	1189
2023 Q2	–	Sell	-688	Closed	-$217K	–	1788
2023 Q1	$217K	Buy	688 +1	+0.1%	+$300	0.07%	281
2022 Q4	$198K	Buy	687 +23	+3%	+$7.01K	0.07%	350
2022 Q3	$192K	Buy	664 +347	+109%	+$99.8K	0.09%	213
2022 Q2	$90K	Sell	317 -402	-56%	-$108K	0.06%	565
2022 Q1	$188K	Buy	719 +367	+104%	+$87.1K	0.09%	224
2021 Q4	$77K	Sell	352 -101	-22%	-$19.6K	0.04%	826
2021 Q3	$82K	Sell	453 -386	-46%	-$75.4K	0.05%	537
2021 Q2	$169K	Buy	839 +467	+126%	+$97.7K	0.11%	245
2021 Q1	$80K	Buy	+372	New	+$81.7K	0.13%	144

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State of Wyoming's VRTX Position: Q2 2026 in Review

State of Wyoming opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 300 shares worth $149K. The stake represents 0.02% of the portfolio and ranks #1194 among its holdings. This is a return to the name: State of Wyoming previously reported a position in VRTX as recently as Q4 2025.

State of Wyoming first reported a position in VRTX in Q1 2021 and has held it in 15 quarters since. The position peaked at $217K in Q1 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

State of Wyoming held 300 shares of Vertex Pharmaceuticals worth $149K as of Q2 2026.
Vertex Pharmaceuticals was a new State of Wyoming position in Q2 2026.
Vertex Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1194 holding.
State of Wyoming first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 15 quarters since.
State of Wyoming's Vertex Pharmaceuticals position peaked at $217K in Q1 2023.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.